Kenya among select countries picked by WHO for launch of long-acting HIV vaccine

Kenya among select countries picked by WHO for launch of long-acting HIV vaccine

Notably, Kenya is among the first countries globally to introduce Lenacapavir for HIV prevention, signalling strong international confidence in the country’s health systems and its ability to responsibly deliver cutting-edge medical innovations.

Read more